Bifalgorithm post · Cancer in 2026: How Immunotherapy Is Reshaping the Odds · Progress Is Real, But Uneven

Health Inequities

Health Inequities (Cancer in 2026: How Immunotherapy Is Reshaping the Odds · Progress Is Real, But Uneven) — "Racial and ethnic inequities persist – driven by…

Ideas in this flowchart

  • Racial and ethnic inequities in cancer outcomes persist
  • Systemic barriers drive these inequities
  • Higher prevalence of risk factors
  • Medical mistrust
  • Lack of insurance hinders access to high-quality health care
  • Survival gaps remain even after controlling for stage at diagnosis and socioeconomic status
  • The largest contributor is less access to high-quality care across the cancer continuum
  • Documented disparities across racial and ethnic groups
  • Black men have prostate cancer death rates two to four times higher than other groups
  • American Indians/Alaska Natives face double the mortality rates for kidney, liver, stomach, and cervical cancers
  • Black women have uterine cancer death rates twice as high as White women
  • Asian, Black, and Hispanic patients are less likely to receive recommended genetic testing, a gateway to targeted therapies
Feed/

Health Inequities

No cover

Channel

Cancer in 2026: How Immunotherapy Is Reshaping the Odds

1 page

"Racial and ethnic inequities persist – driven by systemic barriers. The report emphasizes certain disparities that stem from a “higher prevalence of risk factors, medical mistrust, and lack of insurance, which hinders access to high-quality health care.” Even after controlling for stage at diagnosis and socioeconomic status, survival gaps remain – with the “largest contributor” being “less access to high-quality care across the cancer continuum, from prevention to diagnosis and treatment.” As a result, the report notes the following: Black men have prostate cancer death rates 2–4 times higher than other groups. American Indians/Alaska Natives face double the mortality rates for kidney, liver, stomach, and cervical cancers. Black women have uterine death rates twice as high as White women. Asian, Black, and Hispanic patients are less likely to receive recommended genetic testing–a gateway to targeted therapies."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.